Biosynex开发、制造和销售用于筛查、诊断和预防的医疗设备,不断追求卓越。这些简单易用的测试被卫生专业人士用来帮助病人的护理,也被公众用来监测他们的健康状况。通过这种方式,我们在生命的各个阶段都有助于改善公共卫生。
BIOSYNEX公司位于法国斯特拉斯堡,成立于2005年,专门从事快速诊断测试(RDT)的设计和分销。
自测是RDT的一般公开版本,可在药店获得。这些设备允许对多种应用进行自我监测,例如:HIV、妊娠诊断、排卵期、男性生育能力、尿路感染、阴道感染等。
RDT可供卫生专业人员(分析实验室、医生)用于诊断指导。它们允许在会诊和紧急情况下对患者进行适当的管理。例如,在过去几年中,BIOSYNEX一直为大约50000名自由派医生提供链球菌试验StrepTest®,作为国家雇员健康保险基金(CNAMTS)发起的招标的一部分,这大大改善了细菌性心绞痛的筛查,并限制了抗生素的过度消费。
RDT也可用于分析实验室,以实现分段测试。
BIOSYNEX还将一组可用于POC的仪器和机器商业化,以及基于免疫印迹或分子生物学等确认诊断技术的分析实验室的其他测试
Biosynex develops, manufuactures, and markets medical devices for screening, diagnosis and prevention in a constant quest for excellence. These simple, easy to use tests are used by health professionnals to facilitate the care of patients, and by the general public so that everyone can monitor their health. In this way we contribute to better PUBLIC HEALTH at all stages of life. Located in Strasbourg (France), the BIOSYNEX Company was born in 2005 and specialises in the design and distribution of rapid diagnostic tests (RDT). Today, BIOSYNEX is the leader of the RDT French market. Self-tests are the general public version of RDTs and are available in pharmacies. These allow self-monitoring for multiple applications, such as: HIV, pregnancy diagnosis, ovulation period, male fertility, urinary tract infections, vaginal infections, etc. RDTs may be used by health professionals (analytical laboratories, doctors) for diagnostic orientation. They allow an appropriate management of the patient both in consultation and in emergency. As an example, BIOSYNEX has been supplying around 50,000 liberal doctors with a strep test, Streptatest® for the last few years as part of the call for tenders launched by the National Health Insurance Fund for Employees (CNAMTS), this improving significantly the screening for bacterial angina and limiting the overconsumption of antibiotics. RDTs may also be used in the analytical laboratory for the realization of piecemeal tests. BIOSYNEX also commercializes a panel of instruments and machines which can be used in POC, as well as other tests for analytical laboratories based on technologies for confirmation diagnosis such as immunoblotting or molecular biology